The BioNTech SE ADR BNTX advanced 2.40% to $122.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and the ...
While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...
Company Conference Call October 1, 2024 9:00 AM ETCompany ParticipantsKarim Beguir - Chief Executive Officer, InstaDeepUğur ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...
This AI aims to facilitate interdisciplinary collaboration and uncover unexpected connections in scientific research.
In a report released today, Yaron Werber from TD Cowen maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a price ...
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared ...
AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...
Fintel reports that on September 24, 2024, Morgan Stanley upgraded their outlook for BioNTech SE - Depositary Receipt () ...
Pfizer and BioNTech said drug regulator Health Canada approved their updated Covid-19 vaccine, which will be available in the coming weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback